The document discusses the benefits of prescribing the ACCU-CHEK Combo insulin pump system over competitors like Medtronic for Regence patients. It notes that the ACCU-CHEK system could save patients up to $1,500 due to lower costs through Regence coverage and has several advantages such as discreet design, customizable settings, large insulin cartridges, and 24/7 customer support from Roche. Prescribing the ACCU-CHEK system keeps costs lower for patients and helps them better manage their diabetes.